InvestorsHub Logo
Followers 27
Posts 638
Boards Moderated 0
Alias Born 11/22/2014

Re: None

Friday, 12/22/2023 4:43:23 AM

Friday, December 22, 2023 4:43:23 AM

Post# of 706408
This press release was for the die hard long suffering investors to have something to talk about at Christmas dinner. Sets the stage for whats to come.
Biotech starts anew in January with the various confrences and Asco submissions.. Sell in May and go away is the perenial line.
So starting Jan 02 anything can be announced. New trials,partnerships, who gave us 3 million for placeholder, Manufacturing advancements,partnerships patent approvoals.
The upcoming Preliminary readout of 10 yr trial that ends Jan 2024 with PolyIcl
Biden needs to talk about Cancer moonshoot. We know as investors of nwbo that we are not aware of a better cancer treatment anywhere close to approvoal.We know this because we have heard about every rat study and phase 1 cancer trial from Jondeuk and Learningcurve. Yet we have heard nothing close to dcvax potential with no side effects...And then we have addition of polyicl that may be descibed in the upcoming Nature article.
Exciting times my friends. Nice to have something to look forward too.
While we look forward to being an investor of the company with the possible cure for cancer and we have the chance of getting rich... The others on here 24/7 bashing can only rejoice if this company goes bankrupt and or dcvax fails to get approved.
Think about that logic

So we know nothing compares with dcvax. And especially a drug that completed phase 3 and has now submitted for MHRA approvoal
Big name investor backer coming onboard with a billion dollars because he sees what we see and it would make him look good plus probably 10x his investment by bringing notierity to the stock.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News